Discontinuation report DIFLUNISAL
| Report ID | 108367 |
| Drug Identification Number | 02039494 |
| Brand name | DIFLUNISAL |
| Common or Proper name | DIFLUNISAL |
| Company Name | AA PHARMA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | DIFLUNISAL |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100BTL |
| ATC code | N02BA |
| ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-03-10 |
| Remaining supply date | 2020-03-10 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.